Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...
Accurate risk stratification and treatment selection remain central challenges in cancer care. Rapid advances in medical imaging, digital pathology, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback